Kindred Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Kindred Biosciences generated cash of -$9,857,000, which is more than the previous year. Cash used in financing activities reached the amount of -$282,000 last year. Net change in cash is therefore -$4,366,000.
Cash Flow
| 2012 | -62K | 0 | 1M |
|---|---|---|---|
| 2013 | -1.57M | -14.82K | 65.97M |
| 2014 | -21.93M | -88.61M | 58.18M |
| 2015 | -22.75M | 29.43M | 343K |
| 2016 | -18.78M | 5.31M | 162K |
| 2017 | -21.87M | -2.66M | 52.67M |
| 2018 | -45.03M | 16.60M | 49.92M |
| 2019 | -56.34M | -47.81M | 63.84M |
| 2020 | -9.85M | 5.77M | -282K |
KIN Cash Flow Statement (2012 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 15.98M | 56.30M | 34.81M | 6.68M | 19.99M | 12.96M | 65.32M | 937.51K | 0 |
Operating activities | |||||||||
Net income | -21.79M | -61.38M | -49.69M | -30.87M | -22.49M | -27.13M | -27.13M | -4.21M | -120K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 4.67M | 2.53M | 805K | 475K | 155K | 146K | 58K | 3.12K | 0 |
Stock-based compensation expense | 7.58M | 7.35M | 6.27M | 5.20M | 3.62M | 4.15M | 4.42M | 921.78K | 11K |
| Deferred income tax benefit | 7.58M | 7.35M | 6.27M | 5.20M | 3.62M | 4.15M | 4.42M | 921.78K | 11K |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 352K | -20K | -903K | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 185K | -648K | -3.57M | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -1.16M | 1.83M | 277K | 1.28M | -710K | 30K | -269K | 683.14K | 6K |
Cash generated by operating activities | -9.85M | -56.34M | -45.03M | -21.87M | -18.78M | -22.75M | -21.93M | -1.57M | -62K |
Investing activities | |||||||||
Purchases Of Investments | -75.66M | -125.02M | -25.1M | -70.11M | -72.04M | -102.19M | -145.17M | 0 | 0 |
Investments In Property Plant And Equipment | -3.63M | -8.42M | -13.91M | -5.92M | -952K | -729K | -440K | -14.82K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 5.77M | -47.81M | 16.60M | -2.66M | 5.31M | 29.43M | -88.61M | -14.82K | 0 |
Financing activities | |||||||||
Common Stock Issued | 201K | 43.12M | 49.18M | 52.16M | 0 | 0 | 58.06M | 56.14M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -247K | 0 | 0 | 0 | 0 | -1.27M | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -282K | 63.84M | 49.92M | 52.67M | 162K | 343K | 58.18M | 65.97M | 1M |
Net Change In Cash | -4.36M | -40.31M | 21.48M | 28.12M | -13.30M | 7.02M | -52.36M | 64.39M | 0 |
Cash at end of period | 11.62M | 15.98M | 56.30M | 34.81M | 6.68M | 19.99M | 12.96M | 65.32M | 938K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |